Global Polymeric Biomaterials Market, By Product (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polyurethanes, Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE), Polyaryletheretherketone (PEEK), Polydioxanone (PDO) and Others), B

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	170 Pages	Coherent Market Insights	June, 2025	CMI20173482

Best Price Guarantee
Price	from $4,500
Length	170 Pages
Publisher	Coherent Market Insights
Published Date	June, 2025
SKU	CMI20173482

Polymeric biomaterials are polymers that are biocompatible and are used in medical applications and devices. They plays an important role in tissue engineering and regenerative medicine applications due to their biodegradability and biocompatibility properties. Polymeric biomaterials can be natural polymers such as collagen, elastin or synthetic polymers like polyglycolic acid(PGA), polylactic acid (PLA) or polycaprolactone (PCL). These polymers are attractive candidates for drug delivery vehicles, medical implants, and scaffolds for tissue regeneration due to their tunable physicochemical properties and degradation behavior. Global polymeric biomaterials market is growing at a significant rate due to the increasing use of polymeric biomaterials in cardiovascular, orthopedic, dental and wound healing applications.

Market Dynamics

Global polymeric biomaterials market is primarily driven by the rising prevalence of chronic diseases, growing geriatric population, increasing medical implants and tissue engineering procedures. According to the United Nations, the number of people aged 65 years and above is projected to grow from 703 Mn in 2020 to 1.5 billion by 2050. The increase in ageing population is expected to boost the demand for polymeric biomaterials used in implants, tissue scaffolds and other medical applications. Moreover, development of novel bioabsorbable polymers with tunable degradation properties, versatility in processing techniques and increasing research in regenerative medicine also helps to fuel the market growth. However, stringent regulatory approval process and high costs associated with research and development (R&D) could hamper the market expansion. Nevertheless, growing healthcare investments in emerging nations and ongoing advancements in medical technology are projected to unlock new opportunities over the forecast period.

Key features of the study

This report provides in-depth analysis of the global polymeric biomaterials market, and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global polymeric biomaterials market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Stryker, BASF SE, Evonik Industries AG, DSM, Bezwada Biomedical, LLC, Corbion, Victrex plc (Invibio Ltd.), International Polymer Engineering, Covalon Technologies Ltd., Medtronic, Abbott, Elixir Medical, REVA Medical, LLC, Meril Life Sciences Pvt. Ltd., and MicroPort Scientific Corporation.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global polymeric biomaterials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global polymeric biomaterials market.

Market Segmentation

Global Polymeric Biomaterials Market, By Product
Polylactic Acid (PLA)
Polyglycolic Acid (PGA)
Polyurethanes
Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE)
Polyaryletheretherketone (PEEK)
Polydioxanone (PDO)
Others
Global Polymeric Biomaterials Market, By Application
Cardiovascular
Bioresorbable Stents
Vascular Grafts
Sensors
Guidewires
Implantable Cardiac Defibrillators
Pacemakers
Others
Dental
Tissue Regeneration Materials
Dental Implants
Bone Grafts & Substitutes
Dental Membranes
Dental Sutures
Others
Orthopedic
Joint Replacement Polymeric Biomaterials
Tissue Fixation Products
Suture Anchors
Others
Orthobiologics
Viscosupplementation
Spine Biomaterials
Others
Plastic Surgery
Facial Wrinkle Treatment
Soft Tissue Fillers
Craniofacial Surgery
Sutures
Others
Bioengineered Skins
Peripheral Nerve Repair
Acellular Dermal Matrices
Others
Neurology
Neural Stem Cell Encapsulation
Shunting Systems
Hydrogel Scaffold For CNS Repair
Cortical Neural Prosthetics
Others
Others
Global Polymeric Biomaterials Market, By Region
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Top Companies in the Global Polymeric Biomaterials Market
Stryker
BASF SE
Evonik Industries AG
DSM
Bezwada Biomedical, LLC
Corbion
Victrex plc (Invibio Ltd.)
International Polymer Engineering
Covalon Technologies Ltd.
Medtronic
Abbott
Elixir Medical
REVA Medical, LLC
Meril Life Sciences Pvt. Ltd.
MicroPort Scientific Corporation

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Global Polymeric Biomaterials Market, By Product; Global Polymeric Biomaterials Market, By Application; Global Polymeric Biomaterials Market, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Increasing orthopedic and dental applications; Stringent regulatory environment; Emerging markets in Asia Pacific and Latin America; Key Highlights; Regulatory Scenario; Recent Trends; PEST Analysis; PORTER’s Analysis; Mergers, Acquisitions, and Collaborations
4. Global Polymeric Biomaterials Market, By Product, 2020-2032, (USD Bn): Introduction; Market Share Analysis, 2025 and 2032 (%); Y-o-Y Growth Analysis, 2021 – 2032; Segment Trends; Polylactic Acid (PLA); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn); Polyglycolic Acid (PGA); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn); Polyurethanes; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn); Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn); Polyaryletheretherketone (PEEK); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn); Polydioxanone (PDO); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
5. Global Polymeric Biomaterials Market, By Application, 2020-2032, (USD Bn): Introduction; Market Share Analysis, 2025 and 2032 (%); Y-o-Y Growth Analysis, 2021 – 2032; Segment Trends; Cardiovascular; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn); Bioresorbable Stents; Vascular Grafts; Sensors; Guidewires; Implantable Cardiac Defibrillators; Pacemakers; Others; Dental; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn); Tissue Regeneration Materials; Dental Implants; Bone Grafts & Substitutes; Dental Membranes; Dental Sutures; Others; Orthopedic; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn); Joint Replacement Polymeric Biomaterials; Tissue Fixation Products; Suture Anchors; Others; Orthobiologics; Viscosupplementation; Spine Biomaterials; Others; Plastic Surgery; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn); Facial Wrinkle Treatment; Soft Tissue Fillers; Craniofacial Surgery; Sutures; Others; Bioengineered Skins; Peripheral Nerve Repair; Acellular Dermal Matrices; Others; Neurology; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn); Neural Stem Cell Encapsulation; Shunting Systems; Hydrogel Scaffold For CNS Repair; Cortical Neural Prosthetics; Others; Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
6. Global Polymeric Biomaterials Market, By Region, 2020-2032, (USD Bn): Introduction; Market Share Analysis, By Region, 2025 and 2032 (%); Y-o-Y Growth Analysis, For Region, 2021 –2032; Country Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Bn); U.S.; Canada; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Bn); Germany; U.K.; Spain; France; Italy; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Bn); China; India; Japan; Australia; South Korea; ASEAN; Rest of Asia Pacific; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Bn); Brazil; Argentina; Mexico; Rest of Latin America; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Bn); GCC Countries; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(USD Bn); North Africa; Central Africa; South Africa
7. Competitive Landscape: Company Profile; Stryker; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; BASF SE; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Evonik Industries AG; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; DSM; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Bezwada Biomedical, LLC; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Corbion; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Strategies; Victrex plc (Invibio Ltd.); Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; International Polymer Engineering; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Covalon Technologies Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Medtronic; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Abbott; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Elixir Medical; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; REVA Medical, LLC; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Meril Life Sciences Pvt. Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; MicroPort Scientific Corporation; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Analyst Views
8. Section: References; Research Methodology; About us